Repurposing metformin for the treatment of gastrointestinal cancer
作者机构：Department of Internal MedicineDivision of OncologyUniversity of Campinas(UNICAMP)Campinas 13083-970São PauloBrazil Division of OncologyHospital de Câncer de BarretosBarretos 14784-400São PauloBrazil
出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)
年 卷 期：2021年第27卷第17期
页 面：1883-1904页
核心收录：
学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题：Antidiabetic treatments Gastrointestinal tumors Therapeutic target
摘 要：Diabetes mellitus type 2 and cancer share many risk *** pleiotropic insulin-dependent and insulin-independent effects of metformin might inhibit pathways that are frequently amplified in neoplastic ***,modulation of inflammation,metabolism,and cell cycle arrest are potential therapeutic cancer targets utilized by metformin to boost the anti-cancer effects of *** in vitro and in vivo models have demonstrated the potential of metformin as a chemo-and radiosensitizer,besides its chemopreventive and direct therapeutic activity in digestive system(DS)***,these aspects have been considered in many cancer clinical ***-control and cohort studies and associated meta-analyses have evaluated DS cancer risk and metformin usage,especially in colorectal cancer,pancreatic cancer,and hepatocellular *** clinical studies have demonstrated the protective role of metformin in the risk for DS cancers and survival *** the other hand,the ability of metformin to enhance the actions of chemotherapy for gastric and biliary cancers is yet to be *** article reviews the current findings on the anti-cancer mechanisms of metformin and its apparatus from pre-clinical and ongoing studies in DS malignancies.
维普期刊数据库